- Home
- WFC vs NVS Comparison
WFC vs NVS Comparison
Compare WFC & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFC
- NVS
- Stock Information
- Founded
- WFC 1852
- NVS 1895
- Country
- WFC United States
- NVS Switzerland
- Employees
- WFC N/A
- NVS N/A
- Industry
- WFC Major Banks
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- WFC Finance
- NVS Health Care
- Exchange
- WFC Nasdaq
- NVS Nasdaq
- Market Cap
- WFC 254.4B
- NVS 242.8B
- IPO Year
- WFC N/A
- NVS 1991
- Fundamental
- Price
- WFC $82.20
- NVS $126.51
- Analyst Decision
- WFC Buy
- NVS Hold
- Analyst Count
- WFC 16
- NVS 6
- Target Price
- WFC $81.10
- NVS $123.67
- AVG Volume (30 Days)
- WFC 13.4M
- NVS 1.3M
- Earning Date
- WFC 10-10-2025
- NVS 10-28-2025
- Dividend Yield
- WFC 2.19%
- NVS 2.05%
- EPS Growth
- WFC 19.49
- NVS N/A
- EPS
- WFC 5.82
- NVS 6.85
- Revenue
- WFC $77,618,000,000.00
- NVS $55,186,000,000.00
- Revenue This Year
- WFC $7.81
- NVS $9.01
- Revenue Next Year
- WFC $4.68
- NVS $2.49
- P/E Ratio
- WFC $14.11
- NVS $17.93
- Revenue Growth
- WFC N/A
- NVS 12.95
- 52 Week Low
- WFC $50.22
- NVS $96.06
- 52 Week High
- WFC $84.83
- NVS $128.03
- Technical
- Relative Strength Index (RSI)
- WFC 59.73
- NVS 63.71
- Support Level
- WFC $76.59
- NVS $125.82
- Resistance Level
- WFC $83.21
- NVS $127.07
- Average True Range (ATR)
- WFC 1.54
- NVS 1.20
- MACD
- WFC 0.51
- NVS 0.34
- Stochastic Oscillator
- WFC 81.27
- NVS 84.31
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.